Advanced Cancer
Showing 9951 - 9975 of >10,000
Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- Anti-CD19 and anti-CD20 bicistronic CAR T- cells
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Apr 10, 2023
Solid Tumors Trial in France, United States (MEDI9253, Durvalumab)
Recruiting
- Solid Tumors
- MEDI9253
- Durvalumab
-
La Jolla, California
- +19 more
Jul 28, 2022
Differentiated Thyroid Cancer, Pediatric Cancer, Cancer Trial (Larotrectinib monotherapy, 131I therapy)
Not yet recruiting
- Differentiated Thyroid Cancer
- +3 more
- Larotrectinib monotherapy
- 131I therapy
- (no location specified)
Mar 13, 2023
Prostatic Tumors, Prostatic Tumors, Castration-Resistant Trial in New Orleans (68 Ga-PSMA-11 prepared using a PSMA-11 Sterile
Available
- Prostatic Neoplasms
- Prostatic Neoplasms, Castration-Resistant
- 68 Ga-PSMA-11 prepared using a PSMA-11 Sterile Cold Kit
-
New Orleans, LouisianaTulane Medical Center
Apr 25, 2022
Gastric Cancer, Cancer of the Stomach, Esophagogastric Junction Trial in Worldwide (BMS-986213, Nivolumab, XELOX)
Active, not recruiting
- Gastric Cancer
- +2 more
- BMS-986213
- +4 more
-
Clovis, California
- +77 more
Jan 9, 2023
Melanoma Trial in Worldwide (Immunotherapeutic GSK2132231A)
Completed
- Melanoma
- Immunotherapeutic GSK2132231A
-
Los Angeles, California
- +62 more
Dec 7, 2020
Acute Pain, Cancer Pain Trial in Santiago (Acetaminophen, Placebo)
Completed
- Acute Pain
- Cancer Pain
- Acetaminophen
- Placebo
-
Santiago, ChileUniversidad Catolica de Chile
Aug 12, 2021
Eosinophilic Esophagitis Trial in Worldwide (Etrasimod, Placebo)
Active, not recruiting
- Eosinophilic Esophagitis
- Etrasimod
- Placebo
-
Birmingham, Alabama
- +222 more
Dec 8, 2022
Breast Cancer, Estrogen Receptor Positive Tumor, HER2-positive Breast Cancer Trial in Worldwide (Paclitaxel, Trastuzumab,
Active, not recruiting
- Breast Cancer
- +2 more
- Paclitaxel
- +4 more
-
Brasschaat, Belgium
- +53 more
Nov 29, 2022
Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Malignant Tumor Trial in Los Angeles, Houston
Terminated
- Adenocarcinoma of the Extrahepatic Bile Duct
- +6 more
- trastuzumab
- laboratory biomarker analysis
-
Los Angeles, California
- +1 more
Jul 29, 2019
Hepatocellular Carcinoma (HCC) Trial in China (Brivanib 800 mg, QD, Brivanib 400 mg, BID)
Completed
- Hepatocellular Carcinoma (HCC)
- Brivanib 800 mg, QD
- Brivanib 400 mg, BID
-
Hefei, Anhui, China
- +14 more
Sep 3, 2019
Melanoma Trial in Sydney, Wollstonecraft, Melbourne (Dabrafenib, Trametinib, Pembrolizumab)
Active, not recruiting
- Melanoma
- Dabrafenib
- +2 more
-
Sydney, New South Wales, Australia
- +2 more
Apr 4, 2022
Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)
Recruiting
- Kidney Cancer
- cell infusion
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Dec 2, 2022
NSCLC Stage IV, EGFR Gene Mutation Trial in Worldwide (Osimertinib, Stereotactic Body Radiation Therapy (SBRT))
Recruiting
- NSCLC Stage IV
- EGFR Gene Mutation
- Osimertinib
- Stereotactic Body Radiation Therapy (SBRT)
-
Alessandria, Italy
- +15 more
Mar 29, 2022
Ovarian Cancer, Ovarian Carcinoma, Stage II Ovary Cancer Trial in United States (Mind-body resilience training, Music therapy,
Recruiting
- Ovarian Cancer
- +13 more
- Mind-body resilience training
- +3 more
-
Basking Ridge, New Jersey
- +6 more
Jun 28, 2022
Thyroid Cancer Trial in Suita (Targeted alpha therapy)
Recruiting
- Thyroid Cancer
- Targeted alpha therapy
-
Suita, JapanOsaka University Hospital
Mar 2, 2022
Colorectal Cancer Metastatic Disease in Middle-Norway
Active, not recruiting
- Neoplasms, Colorectal
- Neoplasm Metastasis
- cancer treatment and follow-up according to current regional and national guidelines
-
Kristiansund, Norway
- +6 more
Feb 10, 2022
Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer Trial in Mobile (Cabozantinib 40 MG oral once a day,
Terminated
- Cervical Cancer
- +3 more
- Cabozantinib 40 MG oral once a day
- Pembrolizumab 200 mg IV every 3 weeks
-
Mobile, AlabamaUniversity of South Alabama Mitchell Cancer Institute
Jun 3, 2022
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Springfield (Omega Nutrition cold-milled
Completed
- Epithelial Ovarian Cancer
- +2 more
- Omega Nutrition cold-milled flaxseeds
-
Springfield, IllinoisSouthern Illinois University School of Medicine
Mar 30, 2022
Glioblastoma Trial in Commack, Harrison, New York (Focus Group, Meaning-Centered Psychotherapy for Cancer Caregivers / MCP-C,
Active, not recruiting
- Glioblastoma
- Focus Group
- +2 more
-
Commack, New York
- +2 more
Nov 9, 2022
Ramucirumab and Paclitaxel in Gastric or Gastroesophageal
Completed
- Gastric or Gastroesophageal Junction Adenocarcinoma
-
Ansan, Korea, Republic of
- +56 more
Mar 22, 2021
Esophageal Squamous Cell Carcinoma (ESCC) Trial in Taiwan (BI-754091 plus afatinib)
Enrolling by invitation
- Esophageal Squamous Cell Carcinoma (ESCC)
- BI-754091 plus afatinib
-
Kaohsiung, Taiwan
- +4 more
Aug 30, 2021
Locally Advanced Malignant Tumor, Gastric Cancer Trial in Loma Linda (Hyperthermic Intraperitoneal Chemotherapy (HIPEC))
Completed
- Locally Advanced Malignant Neoplasm
- Gastric Cancer
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
-
Loma Linda, CaliforniaLoma Linda University Cancer Center
Apr 10, 2019
Renal Cell Carcinoma Trial in Macquarie University, Haifa (Belzutifan, Palbociclib)
Recruiting
- Renal Cell Carcinoma
-
Macquarie University, New South Wales, Australia
- +1 more
Aug 15, 2022